Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adaptive immune responses associated with breast cancer relapse.
Payne KK, Manjili MH. Payne KK, et al. Among authors: manjili mh. Arch Immunol Ther Exp (Warsz). 2012 Oct;60(5):345-50. doi: 10.1007/s00005-012-0185-y. Epub 2012 Aug 22. Arch Immunol Ther Exp (Warsz). 2012. PMID: 22911133 Free article. Review.
Danger signals and nonself entity of tumor antigen are both required for eliciting effective immune responses against HER-2/neu positive mammary carcinoma: implications for vaccine design.
Kmieciak M, Morales JK, Morales J, Bolesta E, Grimes M, Manjili MH. Kmieciak M, et al. Among authors: manjili mh. Cancer Immunol Immunother. 2008 Sep;57(9):1391-8. doi: 10.1007/s00262-008-0475-8. Epub 2008 Feb 16. Cancer Immunol Immunother. 2008. PMID: 18278493 Free PMC article.
Radiofrequency thermal ablation of breast tumors combined with intralesional administration of IL-7 and IL-15 augments anti-tumor immune responses and inhibits tumor development and metastasis.
Habibi M, Kmieciak M, Graham L, Morales JK, Bear HD, Manjili MH. Habibi M, et al. Among authors: manjili mh. Breast Cancer Res Treat. 2009 Apr;114(3):423-31. doi: 10.1007/s10549-008-0024-3. Epub 2008 Apr 20. Breast Cancer Res Treat. 2009. PMID: 18425677 Free PMC article.
CD4+ T cells inhibit the neu-specific CD8+ T-cell exhaustion during the priming phase of immune responses against breast cancer.
Kmieciak M, Worschech A, Nikizad H, Gowda M, Habibi M, Depcrynski A, Wang E, Godder K, Holt SE, Marincola FM, Manjili MH. Kmieciak M, et al. Among authors: manjili mh. Breast Cancer Res Treat. 2011 Apr;126(2):385-94. doi: 10.1007/s10549-010-0942-8. Epub 2010 May 18. Breast Cancer Res Treat. 2011. PMID: 20480224 Free PMC article.
Activated NKT cells and NK cells render T cells resistant to myeloid-derived suppressor cells and result in an effective adoptive cellular therapy against breast cancer in the FVBN202 transgenic mouse.
Kmieciak M, Basu D, Payne KK, Toor A, Yacoub A, Wang XY, Smith L, Bear HD, Manjili MH. Kmieciak M, et al. Among authors: manjili mh. J Immunol. 2011 Jul 15;187(2):708-17. doi: 10.4049/jimmunol.1100502. Epub 2011 Jun 13. J Immunol. 2011. PMID: 21670315 Free PMC article.
120 results